Biomaterials, tissue engineering & 3D printing
Live Webinar: 19 March 2020, 4pm CET
A joint initiative between ECTS and TERMIS-EU
Date & Time: 19 March 2020, 4pm CET
Featuring Maria-Pau Ginebra and moderated by Bram van der Eerden
Costs: Live webinar is free for ECTS members and non-members, but a registration is required. Recordings are accessible to ECTS members only.
Format:
- 5 min welcome & introductions
- 35 min presentation
- 20 min Q&A
Webinar Objectives
- Understand how materials engineering can contribute to the design of synthetic bone grafts for bone regeneration
- Discuss the potential impact and current limitations of bone tissue engineering
- Learn how 3D printing technologies are making an impact in the treatment of bone lesions
- Discuss the open challenges in the field of high performance synthetic bone grafts
About the speaker
Maria-Pau Ginebra is full professor and Head of the Department of Materials Science and Engineering at the Universitat Politècnica de Catalunya (UPC) in Barcelona, Spain, as well as Director of the Biomaterials, Biomechanics and Tissue Engineering Group. Her focus is on the processing and characterisation of a new generation of calcium phosphate biomaterials, which imitate the extracellular matrix of bones.
Furthermore, she explores new strategies of biofabrication, including injectable cements and foams, scaffolds for tissue engineering and 3D printing of implants for regenerative medicine. She is author of more than 200 articles in peer reviewed international journals. She is actively involved in translational research to the clinics and industry, being the inventor of 10 patents. In 2013 she founded Mimetis Biomaterials, a spin-off company that manufactures bioinspired synthetic bone grafts.
Moderated by Bram van der Eerden
Bram van der Eerden studied Biology in Utrecht (the Netherlands) and received his PhD in 2002 in Leiden (the Netherlands) working on the hormonal regulation of growth plate cartilage. Since then, he has been working within the department of Internal medicine of the Erasmus MC in Rotterdam on the role of calcium channels in bone and is now mainly involved in the functional characterization of novel compounds/genes/pathways that are anabolic to bone, using in vitro and in vivo models. Currently, he is group leader of the laboratory for Calcium and Bone Metabolism of Internal Medicine at the Erasmus MC. Bram has (co)-authored >50 peer-reviewed papers, has been board member of the Dutch Calcium and Bone Metabolism Society (NVCB) for 6 years and is now in the Bone networking group of the Dutch Society for Endocrinology. He was co-chair of the IBMS young investigator committee and is currently chairing the ECTS Webinar Committee. He has been involved in a number of international projects, including an ongoing Horizon2020 Marie-Curie Staff Exchange project (RUBICON) focusing on the molecular pathways in connective tissue diseases. His research group consists of 2 senior scientists, 1 Post-doc, 4 PhD students and 2 technicians.
